Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report.
Felix EhretAlexander HanschJenny MeinhardtElisabeth Gertrud HainMartin MischJulia OnkenSiyer RoohaniArend KochLeonille SchweizerJosefine RadkeDavid KaulPublished in: Neuropathology and applied neurobiology (2022)